Sensipar 30 mg Oral Tablet
RxNorm 656137
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 656137 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Sensipar 30 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
Cinacalcet 30 mg Oral Tablet [Sensipar]
(Atom ID: 2559820)
SYPrescribable
Synonym (SY):
Sensipar 30 mg (as cinacalcet hydrochloride 33 mg) Oral Tablet
(Atom ID: 4613009)
PSNPrescribable
Prescribable Name (PSN):
Sensipar 30 mg Oral Tablet
(Atom ID: 6359217)
SYPrescribable
Synonym (SY):
Sensipar 30 mg Oral Tablet
(Atom ID: 2559821)
Patient Education
Cinacalcet
Cinacalcet is used alone or with other medications to treat secondary hyperparathyroidism (a condition in which the body produces too much parathyroid hormone [a natural substance needed to control the amount of calcium in the blood] which can cause serious problems with the bones, heart, blood vessels, and lungs) in patients with chronic kidney disease (condition in which the kidneys stop working slowly and gradually) who are being treated with dialysis (medical treatment to clean the blood when the kidneys are not working properly). Cinacalcet is also used to treat high levels of calcium in the blood of patients who have parathyroid cancer (cancer of the glands in the neck that make parathyroid hormone). Cinacalcet is in a class of medications called calcimimetics. It works by signaling the body to produce less parathyroid hormone in order to decrease the amount of calcium in the blood.
[Learn More]
* Please review the disclaimer below.